03Recent Activity
Participated in CoMind's $60M Series A for non-invasive neurotechnology and optical brain monitoring.
OCT 2025
CoMind is developing innovative neuromonitoring devices and neural interfaces to redefine the way the brain is measured and treated, optimizing patient outcomes through non-invasive techniques
CoMind is developing innovative neuromonitoring devices and neural interfaces to redefine the way the brain is measured and treated, optimizing patient outcomes through non-invasive techniques.